安体舒通治疗老年充血性心力衰竭的疗效与安全性

目的观察安体舒通在老年充血性心力衰竭患者中应用的疗效及安全性。方法本组96例65岁以上患充血性心力衰竭患者,随机分为两组,A组48例,在常规治疗基础上,口服安体舒通;B组48例,常规治疗。疗程4周。结果两组患者治疗有效率无明显差别,最佳显效时间A组明显高于B组。结论安体舒通适用于65岁以上的老年充血性心衰患者,但要注意剂量。     

充血性心力衰竭抗醛固酮治疗46例临床分析

目的：观察充血性心力衰竭抗醛固酮治疗的疗效。方法：对８６例充血性心力衰竭患者分２组，以卡托普利联合应用安体舒通为治疗组（４６例），以常规治疗为对照组（４０例）。结果：治疗组水肿明显消退，肺部罗音呈明显减少，症状改善，与常规组对照，疗效显著升高。结论：充血性心力衰竭应早期，持续应用卡托普利和安体舒通。     

ACEI 联合小剂量安体舒通对左室重构和胶原更新的影响

目的：观察ACEI加安体舒通对心脏胶原更新和左室重量的影响。方法：临床研究随机入选原发性高血压患者135人,随机分入A(ACEI 安体舒通)、B(ACEI)、C(非RAAS干预治疗)三组,同等控制血压,观察1年,比较3种治疗方案对心肌胶原更新和左室重量的影响。结果：临床研究显示在同等控制血压的前提下,减低血清PⅢNP的疗效及减低左室重量指数,ACEI联合抗醛固酮治疗优于单纯ACEI治疗,优于非RAAS干预治疗。结论：原发性高血压患者应用ACEI联合抗醛固酮治疗比单纯ACEI治疗更好的减低血清pⅢNP和左室重量指数,并使心肌间质胶原沉积明显减低,而且该作用不依赖于血压下降。     

曲美他嗪和安体舒通联合治疗对充血性心力衰竭患者心功能的影响

目的:探讨曲美他嗪和安体舒通联合治疗对充血性心力衰竭患者心功能的影响。方法:将55例充血性心力衰竭患者随机分为两组。对照组28例,予常规治疗;治疗组27例,在常规治疗基础上加用曲美他嗪和安体舒通治疗。结果:治疗组心功能改善总有效率达92.6%,而对照组总有效率为71.5%,两组比较差别有统计学意义(P<0.01)。结论:曲美他嗪和安体舒通联合治疗明显改善心功能。     

美托洛尔、依那普利和安体舒通联合治疗充血性心力衰竭疗效观察

①目的观察美托洛尔、依那普利和安体舒通3种药物联合治疗充血性心力衰竭（CHF）患者的临床疗效。方法选择CHF患者86例,随机分成两组：对照组（42例）常规给予强心、利尿、给氧、静卧治疗;观察组（44例）在此基础上加用美托洛尔、依那普利和安体舒通治疗。结果观察组与对照组的有效率分别为90.9%、69.0%（P〈0.05）,观察组对心功能的改善明显优于对照组。结论在传统治疗基础上加用β受体阻滞剂、ACEI和醛固酮受体拮抗剂联用治疗CHF是有效的治疗方法。     

坎地沙坦联用安体舒通治疗充血性心力衰竭66例的临床观察

目的：观察血管紧张素受体拮抗剂坎地沙坦联用醛固酮拮抗剂安体舒通治疗充血性心力衰竭的疗效。方法：应用坎地沙坦（candesartan）4 mg,每日1次联用安体舒通40 mg/d治疗心衰,连续用6个月;与对照组常规抗心衰治疗相比较,观察临床心功能、心脏彩色超声心功能测定改善情况以及对心衰死亡的影响。结果：治疗6个月心功能改善有效率、死亡率、LVEF、LVEDD和LVESD改善治疗组均优于对照组。结论：运用血管紧张素受体拮抗剂坎地沙坦联用醛固酮拮抗剂安体舒通治疗充血性心力衰竭效果优于常规心衰治疗。     

心血通治疗充血性心力衰竭患者疗效的临床观察

目的　观察心血通对充血性心力衰竭患者的治疗效果。方法　选用 30例充血性心力衰竭患者分别用心血通加常规治疗和常规治疗对照研究 ,疗程 2周 ,在治疗前后分别观察患者的心功能变化及左室射血分数 (EF)值变化 ,分别用 χ2 及 t检验行统计学处理。结果　用心血通组 2周后心功能改善总有效率 80 % ,明显高于对照组(P <0 .0 5 )。结论　心血通是治疗充血性心力衰竭的一种有效的制剂     

安体舒通与依那普利治疗充血性心力衰竭76例

我们自1995-10／1999-12应用安体舒通与依那普利治疗充血性心力衰竭76例，并和常规治疗组对比观察，现报告如下。     

螺内酯在慢性充血性心力衰竭治疗中的价值

目的 研究醛固酮拮抗剂--螺内酯(Spironolactone)对慢性左室收缩功能障碍患者左室功能的影响.方法 将125例以慢性左室收缩功能障碍为主的充血性心力衰竭患者随机分成治疗组61例和对照组64例.对照组采用常规抗心力衰竭治疗,治疗组在此基础上加用螺内酯,剂量为10-40 mg/d.治疗前后超声心动图检测左室收缩末期容积(LVESV)、左室舒张末期容积(LVEDV)和射血分数(LVEF).结果 对照组治疗后较治疗前LVESV下降,LVEF升高(P均<0.05);治疗组治疗后较治疗前LVEF升高,LVESV下降,心功能改善(P均<0.05),且LVESV及心功能级别与对照组治疗后比较差异有统计学意义(P均<0.05).结论 螺内酯通过阻断醛固酮,明显改善充血性心力衰竭患者左室收缩功能,在心力衰竭治疗中加用螺内酯可改善慢性充血性心力衰竭患者的预后.     

安体舒通和依那普利治疗慢性心力衰竭的临床观察

目的 观察安体舒通和依那普利治疗慢性心力衰竭的疗效.方法 2005-01～2006-01共收治慢性充血性心力衰竭患者100例.全部予以安体舒通、依那普利治疗.治疗早期:安体舒通10～60mg/d,依那普利5～10mg/d,病情稳定后,安体舒通即以最小有效量长期维持,依那普利以足量维持治疗.结果 显效80%,有效15%,无效5%,总有效率95%,无效率5%.结论 安体舒通、依那普利治疗慢性充血性心力衰竭的疗效肯定,安全性好.     

APPLICATION OF LORNOXICAM TO PATIENT-CONTROLLED ANALGESIA IN PATIENTS UNDERGOING ABDOMINAL SURGERIES

FOR anesthesiologis s ,treatingpostoperativepainhas alwaysbeen a problem.Althoughopioidshave been provedtobe effective,theirsideeffectscouldnotbeignored.With thedevelopmentofscienceand pharmacology,many drugs with aspectsof satisfactoryanalgesicefficacyand couldbe welltoleratedby patientshave been developed.And lornoxicamisone of them, which isa non-steroidalanti-inflammatorydrug (NSAID ), with analgesic, anti-infl-ammatory,andantipyreticproperties.Itseliminationhalf-time(3 to 5 hours) isle…     

Dr.Zhang Ren''''s Experience in the Acupuncture Treatment of Different Diseases with the Same Therapeutic Principle

Dr.Zhang Ren,the chief physician,is the chairman of Shanghai Acupuncture and Moxibustion Association.Having been engaged in medicine for about 40 years,he is experienced in treating various intractable diseases.In his long years of clinical practice,he advocates taking the TCM differentiation as the basis to seek for the acupuncture method for treatment of modern intractable diseases.The author of this essay had the fortune to follow Dr.Zhang in study.The following is a summary of Dr.Zhang's experience in the acupuncture treatment for different intractable diseases with the same therapeutic principle.     

Luo Lingjie''''s Experience in Treating Chronic Nephropathy

In treating chronic nephropathy,Luo Lingjie,a chief physician,pays attention to regulating the balance between yin and yang,treating infection if present,and removing pathogenic factors.He prescribes gentle drugs and uses carefully strongly warming-tonifying ones,emphasizes the importance of persuading the patient to persist in treatment with medication and nurse one's health for recuperation,and is good at combined use of TCM and western medicine therapy and brings the merits of various therapies into full play,with obvious theraoeutic effects.     

Acupuncture Combined with Spinal Tui Na for Treatment of Primary Dysmenorrhea in 30 Cases

Objective: To observe the therapeutic effects in acupunture treatment of primary dysmenorrhea combined with spinal Tui Na, and study its mechanism. Methods: Thirty cases of the treatment group were treated by acupuncture combined with spinal Tui Na, and thirty cases in the control group were treated by routine acupuncture. Results: The total effective rate was 93.3% in the treatment group, and 73.3% in the control group, with a significant difference between the two groups (P<0.05). Conclusions: Acupuncture combined with spinal Tui Na has good prospects for treatment of primary dysmenorrhea.     

猪肺磷脂注射液联合经鼻持续气道正压通气对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性的影响

目的 探讨猪肺磷脂注射液联合经鼻持续气道正压通气(NCPAP)对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性(CK-MB)的影响.方法 选取呼吸衰竭早产儿80例,分为观察组和对照组各40例.对照组采用NCPAP给氧治疗,观察组给予NCPAP给氧联合猪肺磷脂气管内给药.观察两组患儿治疗前及治疗12h、24 h后PaO2、PaCO2、血氧饱和度(SaO2)、pH的变化情况,检测治疗前及治疗5d后血清CK-MB水平;评估两组患儿的临床治疗效果.结果 两组患儿PaO2、PaCO2、SaO2、pH比较,差异均有统计学意义(P＜0.05),其中观察组治疗后的PaO2、SaO2、pH均高于对照组,PaCO2则低于对照组.两组的PaO2、SaO2、pH均随观察时间延长而升高(P＜0.05),PaCO2均随观察时间的延长而降低(P＜0.05).观察组治疗有效率为87.5％,显著高于对照组的70.0％ (P ＜0.05).治疗5d后两组患儿血清CK-MB水平均较前降低(P＜0.05),且观察组明显低于对照组(P＜0.05).结论 猪肺磷脂注射液气管内给药联合NCPAP可以显著降低呼吸衰竭早产儿CK-MB的含量,提高治疗有效率,起到很好的呼吸循环支持作用.     

Acupuncture Treatment of Vomiting

CASE HISTORY A female patient, 46 years old, head of the foreign affairs department of a certain university in Beijing, paid her first visit on October 9, 2006, with the chief complaint of vomiting for one month. She got vomiting after meals in early September. Before that, she had discomfortable sensation in the stomach due to angry with others, but she didn't pay much attention. Later, it developed into vomiting after eating. After the vomiting, the discomfort would be relieved, but with slight hypodynamia. She was once diagnosed as having 'neurogenic vomiting'. Having taken some western and Chinese drugs, the above symptoms were a little bit improved, but she would have nausea upon eating and with regurgitation. Because of the fear for vomiting, she did not dare to have food intake, with body weight reduction of 6 kilos in one month.     

Qiu Baoguo''''s Experience in Treating Consumptive Syndromes after Radio-Chemotherapies

Radiotherapy and chemotherapy are the important modern medical therapies for malignant tumors,yet they can also bring about serious local and systemic toxic side reactions so to decrease the patient;'s life quality,manifested by a series of consumptive symptoms.Having engaged in the combined work of Chinese and western medicine for nearly 50 years,the research fellow Qiu Baoguo in Henan Provincial Academy of TCM has developed his unique views on the TCM study of consumptive syndromes.The author of this essay had once the fortune tO follow Dr.Qiu in clinic,and specially would like to introduce in the following Dr.Qiu's experience in treating consumptive syndromes after radio-chemotherapies for patients with malignant tumor.     

Insomnia Due to Deficiency of Both the Heart and Spleen Treated by Acupuncture-Moxibustion and Chinese Tuina

OBJECTIVE: To observe therapeutic effects of the comprehensive therapy of acupuncture-moxibustion and Chinese Tuina for treatment of insomnia due to deficiency of both the heart and spleen. METHODS: 92 cases were divided randomly into the treatment group (treated by acupuncture-moxibustion and Chinese Tuina) and the control group (treated by acupuncture-moxibustion). RESULTS: The therapeutic effect of the treatment group was obviously superior to that of the control group (the CHI2 test showed P < 0.01). CONCLUSIONS: The comprehensive therapy of acupuncture-moxibustion and Chinese Tuina can give marked therapeutic effects for treatment of insomnia due to deficiency of both the heart and spleen.     

Survey and practice of reporting quality of randomized controlled clinical trials on traditional Chinese medicine

Evidence obtained from randomized controlled trials （RCTs） has been generally accepted as the gold standard in the evaluation of clinical effectiveness. Readers need to understand the trial design, implementation, results, analysis and interpretation, so as to fully Jnderstand the results of RCTs. Thus, the investigators of RCTs have to report these items in a complete, accurate and clear manner. Since 1998, we have conducted several evaluations on the reporting quality of RCTs published in Chinese journals on traditional Chinese medicine （TCM） and results have shown that there is an urgent need for higher quality RCTs on TCM.